P.017 Lamivudine monotherapy can favour the emergence of viral quasispecies with lower susceptibility to other nucleos(t)ide analogues

MLA

Moriconi, F., et al. “P.017 Lamivudine Monotherapy Can Favour the Emergence of Viral Quasispecies with Lower Susceptibility to Other Nucleos(t)Ide Analogues.” Journal of Clinical Virology, vol. 36, no. s2, July 2006, p. S66. EBSCOhost, https://doi.org/10.1016/s1386-6532(06)80201-5.

APA

Moriconi, F., Flichman, D., Ciccorossi, P., Coco, B., Sacco, R., Oliveri, F., Colombatto, P., Bonino, F., & Brunetto, M. (2006). P.017 Lamivudine monotherapy can favour the emergence of viral quasispecies with lower susceptibility to other nucleos(t)ide analogues. Journal of Clinical Virology, 36(s2), S66. https://doi.org/10.1016/s1386-6532(06)80201-5

Chicago

Moriconi, F., D. Flichman, P. Ciccorossi, B. Coco, R. Sacco, F. Oliveri, P. Colombatto, F. Bonino, and M. Brunetto. 2006. “P.017 Lamivudine Monotherapy Can Favour the Emergence of Viral Quasispecies with Lower Susceptibility to Other Nucleos(t)Ide Analogues.” Journal of Clinical Virology 36 (s2): S66. doi:10.1016/s1386-6532(06)80201-5.